⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRUS News
Merus N.V. Common Shares
Genmab Publishes 2025 Annual Report
globenewswire.com
GMAB
HALO
ABBV
MRUS
NVS
JNJ
HRZN
EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
AVBP
SMMT
MRUS
MRK
GNPX
CGEM
ABBV
BMY
BDTX
LTRN
PFE
JNJ
LLY
Zenocutuzumab‑zbco Receives FDA Orphan Drug Designation for Treatment of Cholangiocarcinoma
prnewswire.com
MRUS
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B
prnewswire.com
ONCY
AVBP
MRUS
HALO
AIM
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period
businesswire.com
GMAB
MRUS
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period
globenewswire.com
GMAB
MRUS
Pancreatic Cancer Market Set to Expand During the Forecast Period (2025-2034) as Precision Medicine and Immunotherapy Transform Treatment Landscape | DelveInsight
prnewswire.com
BNTX
NVCR
ONCO
AZN
MRK
MRUS
Zenocutuzumab-zbco (BIZENGRI®) Shows Durable Efficacy in Patients with Treatment-Naïve NRG1+NSCLC: Updated eNRGy Trial Results Presented at IASLC-ASCO NACLC
prnewswire.com
MRUS
Genmab Announces Closing of Private Offering of Senior Secured Notes and Senior Unsecured Notes
globenewswire.com
GMAB
MRUS
MiRus Announces First Cases with EUROPA® Posterior Cervical Fusion System with New Technology Add-on Payment (NTAP)
prnewswire.com
MRUS